α-Synuclein may synergistically interact with β-amyloid and tau protein to promote their accumulation [71] and may be involved in the pathogenesis of AD in addition to synucleinopathie (e.g., Parkinson’s disease) [72, 73]. Here, MAPT is linked to Alzheimer disease.